
Sign up to save your podcasts
Or
Ever notice how some people seem to be naturally resistant to certain diseases? Today, we're diving into the world of natural protective antibodies with Alchemab Therapeutics. Alchemab is developing a pipeline of antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development Manager at AWS, speaks with Young Kwon, the CEO of Alchemab, about his journey, the company's unique approach to drug discovery, and how technology is accelerating their progress.
Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.
Please take a moment and let us know what you think of the podcast, access our feedback survey here.
5
2222 ratings
Ever notice how some people seem to be naturally resistant to certain diseases? Today, we're diving into the world of natural protective antibodies with Alchemab Therapeutics. Alchemab is developing a pipeline of antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development Manager at AWS, speaks with Young Kwon, the CEO of Alchemab, about his journey, the company's unique approach to drug discovery, and how technology is accelerating their progress.
Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.
Please take a moment and let us know what you think of the podcast, access our feedback survey here.
7,683 Listeners
8,636 Listeners
1,014 Listeners
504 Listeners
111,121 Listeners
31 Listeners
15,311 Listeners
617 Listeners